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Abstract

Introduction

In this study, urine from a calcium oxalate kidney
stone former was ultrafiltered (10 kD cut-off). Crystallization was induced in the ultrafiltrate and retentate
fractions as well as in a sample of the whole urine. The
progress of crystallization was monitored by Coulter
Counter and flow cytometry techniques. (The latter has
not been used in studies of the role of urinary macromolecules in urolithiasis). Deposited crystals were
examined by scanning electron microscopy. Results
indicated that urinary macromolecules in this subject are
inhibitors of nucleation and aggregation. These results
agree with the findings of some workers but disagree
with those of others. Indeed, studies on the role played
by urinary macromolecules in promoting or inhibiting
urolithiasis have failed to produce consistent findings.
Examination of the literature reveals that a wide variety
of experimental techniques and crystallization systems
have been used in these studies and that this might be
the cause of the inconsistencies. Based on reported
experiences and those of the present study, a standard
reference crystallization system is proposed. The key
elements of this system involve the use of real urine,
ultrafiltration, continuous crystalliz.er equipment, Coulter
Counter procedures and scanning electron microscopy.

During the past several years many studies have
addressed the question of the role played by urinary
macromolecules (UMM) in urolithiasis. Particular interest has been focused on their influence on calcium oxalate stone formation . Three general approaches have
been adopted. First, workers have investigated the nature and composition of UMM in actual stones and have
examined the structure and ultrastructure of such concretions [38, 44, 62]. Second, several studies have attempted to identify differences in the composition and
concentration of UMM in the urine of stone formers and
normal controls [3 , 4, 15, 16, 17, 27 , 29, 31, 37, 57,
61] . Finally, in vitro crystallization studies have been
conducted in aqueous solutions [1 , 12, 20, 33 , 34, 36,
39, 43, 56, 58], synthetic urines [9, 10, 18, 32, 40, 42,
45, 63] and real urines [2, 5, 6, 11, 21, 24, 47, 48 , 50 ,
51, 55, 59 , 60] in the presence or absence of various
UMM which have either been added to or removed from
the test sample.
Studies employing the first approach are in agreement that hyaluronic acid and heparan sulphate are the
main glycosaminoglycans in the matrix component of
urinary calculi while chondroitin sulphate is absent [38,
44]. This has been interpreted as indicating that the
former are promoters [38] while the latter is an inhibitor
of stone formation [38] .
Results obtained in studies employing the second
approach are inconsistent. Some studies have reported
significant differences between stone formers and normals with respect to UMM excretions or concentrations
or composition [15, 17, 31, 37, 61] while others have
failed to find any such differences [4, 16, 27, 29, 57].
With regard to the third approach, the literature
abounds with numerous examples of apparently conflicting findings, and it is in this area of investigation that
we wish to focus attention. Some studies have found
that UMM are inhibitors of calcium oxalate "growth" [ 1,
2, 5, 6, 12, 34, 36, 39, 56] - a term used synonymously
with "formation" and "precipitation" - while others have
found them to be promoters [24, 48, 50, 51]. On the
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Figure l. Coulter Counter plots of particle number
versus (vs) time for FILT, UF and RET fractions.

Figure 2. Coulter Counter plots of particle volume vs
time for FILT, UF and RET fractions.

other hand, several workers have conducted sophisticated experiments in which they have been able to be more
specific about the aforementioned crystalliz.ation and precipitation processes. These studies have shown that
UMM are inhibitors of calcium oxalate crystal growth
[9, 20, 21, 42, 43, 45, 52, 59, 60, 63] and inhibitors of
aggregation [10, 11, 19, 26, 33, 45, 52, 55 , 58] but are
promoters of calcium oxalate nucleation [9, 21, 42, 45 ,
47, 59, 60, 63] . As might be expected, there is not
much consensus in these findings either. For example,
in contrast to some of the previously mentioned studies,
Edyvane and co-workers showed that UMM (MW > 10
kD) did not affect the calcium oxalate metastable limit
and concluded that therefore they had no effect on nucleation [11] while Gill and associates found that UMM
(MW > 12 kD) inhibited nucleation [18]. Similarly,
Gjaldbaek [19] failed to demonstrate any inhibition by
chondroitin sulphate while Kohri et al. [32], in their
studies of three UMM , found them to be inhibitors of
nucleation and promoters of growth. In a more recent
study, Kavanagh and co-workers found that heparin and
hyaluronic acid significantly reduced nucleation rates but
increased growth rates [30] .
The complexity ofUMM inhibitor/promoter activity
is highlighted by studies which have shown that different
UMM fractions might have different functions [2, 51].
The concept of synergism too has been raised by some
workers [2, 21, 52]. Alternatively, UMM are often
considered as though they were a single substance without reference to the fact that the term includes glycosaminoglycans, Tamm-Horsfall proteins and many other
substances, each of which may have its own inhibitory
or promotory effects upon crystal formation. Others
have drawn attention to more fundamental issues concerning, for example, the possible modification of UMM

structure and hence activity as a result of the particular
isolation or concentration procedure employed [2, 34].
Many aspects of the relationship between UMM and
calcium oxalate stone formation remain ill-defined and
unresolved. The present paper reviews methodologies
and approaches that have been employed in studies of
UMM and describes a new and powerful technique, flow
cytometry, that might prove useful in elucidating the role
of UMM in urolithiasis. In addition, an attempt is made
in this paper to identify, on theoretical grounds, why
conflicting results have been reported so frequently in
the past and to propose a standardized system that
investigators might consider implementing.
Materials and Methods
A single 24-hour urine (pH 5. 8) was collected from
a male idiopathic kidney stone former of age 24 years.
The specimen was stored in a glass bottle at 4 °C during
the collection period. No preservative was present.
Crystals, cellular debris and proteinaceous material were
removed by sieving (74 µm) and filtration {Sartorius cellulose acetate 0.45 µm filter (Sartorius AG , Goettingen,
Germany)} , although it is recognized that material lost
in this way may include substances on which macromolecules may be adsorbed. Henceforth, this urine
fraction will be referred to as FILT.
Aliquots of the FILT fraction were then ultrafiltered
using an Amicon stirred ultrafiltration cell (Amicon
Corp., Danvers, MA, USA) containing a Diaflo Type
YM 10 membrane (Amicon) with a molecular weight cutoff of 10 kD. A pressure of 3.7 atm (2812 torr) was
maintained within the cell by nitrogen gas. Two further
fractions, ultrafiltrate and retentate (henceforth, referred
to as UF and RET), were obtained from this procedure.
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Figure 3. Flow cytometer plots of particle number vs time for FILT, UF and RET fractions.
Figures 4-6. Flow cytometer plots of particle number vs time in four relative size zones in: the FILT fraction (Fig.
4); the UF fraction (Fig. 5); and the RET fraction (Fig. 6).

-------------------------------------------------------------------------------------------------The degree of ultrafiltration was 3-fold. After ultrafiltration was complete, the membrane was examined for
solid deposits by optical microscopy.
The calcium oxalate limit of metastability in the
FILT fraction was determined by titration with aqueous
sodium oxalate solution and was defined by the concentration of sodium oxalate which caused a sudden increase in particle number. A flow cytometer (described
below) was used for this purpose.
Calcium oxalate crystallization was then induced at
37°C in the fractions FILT, UF and RET, by administration of a dose of aqueous sodium oxalate equivalent
to the previously determined metastable limit of the
FILT fraction. This amounted to the addition of 1 cm3
of 0.04 M sodium oxalate solution per 100 cm3 of test
fraction. Since the dose given to each fraction was identical, their respective responses could be compared
effectively.
The progress of calcium oxalate crystallization in
each fraction was followed by two independent techniques: Coulter Counter and flow cytometry. A Coulter
Multisizer (aperture size 140 µm) and an Epics Flow

Cytometer equipped with an argon laser were used for
this purpose. Both instruments were obtained from
Coulter Electronics Ltd., Luton, England. Alignment
and focusing of the sample stream and laser beam (flow
cytometer) were performed daily. While the Coulter
Counter has been widely used for the measurement of
particle size-distribution profiles in many studies involving urinary calcium oxalate crystallization processes,
flow cytometry has only recently been used for the first
time in this field [49) . Its application in the study of
urinary macromolecules has not been previously reported. Briefly, in a flow cytometer, particles in liquid
suspension are passed through a laser beam. The scattered light is detected and provides data concerning particle size, number and morphology. Crystallization was
monitored for 90 minutes (as advocated by Ryall and coworkers [53)) using both techniques. In addition to
Coulter and flow cytometry techniques, scanning electron microscopy (SEM) was performed on the deposited
crystals in each fraction. A Leica Cambridge S440
(Leica, Rockleigh, NJ) sigma scanning electron microscope was used for this purpose.
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ally to show the distribution of particles in various arbitrarily defined size zones. In the present study, the distribution was divided into four such zones: small, medium, large and very large; these are shown as a function
of time in Figures 4, 5 and 6. (Definition of these size
zones is based on relative size and not on absolute size
[49] . However, zone sizes can be calibrated by using
beads of appropriate cross section). As mentioned earlier, flow cytometry can distinguish between different
morphologies and can output data concerning the number
of particles corresponding to different shapes. Figures
7, 8 and 9 show that two different types of structure
were identified in each fraction; the plots show how the
number of particles of both types varied with time.
No solid material was detected on the membrane after ultrafiltration. However, SEM of the FILT specimen
revealed the presence of only a few calcium oxalate
dihydrate (COD) crystals. These were small ( < 5 µm
cross section) and mainly single, but small aggregates
were occasionally observed (Fig. 10). The UF fraction
had more crystals than in the FILT sample; these appeared to be slightly larger (Fig. 11). In addition, aggregates were observed more frequently (but not in great
numbers), and these were large (Fig. 12). Apatite deposits (Figs. 13 and 14) confirmed by energy dispersive
X-ray analysis were also detected. In some cases,
embedded COD crystals were observed (Fig. 13). RET
fractions did not show any COD crystals.
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Isolation and separation procedures can induce conformational changes in UMM which will modify their
adsorption onto mineral surfaces as well as their binding
properties [2, 34] . Among the procedures that have
been used frequently are dialysis [l, 6, 18, 20, 36, 56,
58] and ultrafiltration [2, 5, 11 , 12, 21, 24, 31, 33 , 42,
47, 48, 50, 51 , 55 , 60, 63]. Bio-Gel filtration, ion
exchange chromatography and protein precipitation have
also been used [34]. Thus, the role of UMM, as deduced in in vitro experiments, may be influenced by the
technique used for their original isolation.

Figures 7-9. Flow cytometer plots of number vs time
for different particle types (i.e., morphologies) in: the
FILT fraction (Fig. 7); the UF fraction (Fig. 8); and the
RET fraction (Fig. 9).

Results
Coulter Counter plots of particle number vs time
and total particle volume vs time for the three fractions
are given in Figures 1 and 2 respectively. Figure 3
gives plots of total particle number vs time for each
fraction as determined by flow cytometry. Each of the
three plots shown in Figure 3 can be re-plotted individu-

Nature of the crystallization system
It has been pointed out by other workers that most
of the discrepancies concerning the role of UMM are
due to the wide variety of crystallization systems that
538

Studies of urinary macromolecules

Figures 10-14. Scanning electron micrographs of:
small, single and aggregated calcium oxalate dihydrate
crystals occasionally observed in the FILT fraction (Fig.
10); calcium oxalate dihydrate crystals (Fig. 11) and
aggregate (Fig. 12) observed in the UF fraction; and
apatite deposits with embedded calcium oxalate dihydrate
crystals (arrows; Fig. 13) and apatite deposits (Fig. 14)
observed in the UF fraction.

---------------------------highly sensitive to and dependent upon the crystalliz.ation
milieu in which they are present. This milieu encompasses not only the nature of the crystalliz.ation system
but also possible additive, competitive or synergistic
influences of all UMM components, some of which may
be inhibitors and some of which may be promoters.
Others may even have a dual inhibitor-promoter capacity
depending on experimental conditions [23, 25). Indeed,
the performance of UMM may also be dependent on the
presence of other urinary components which themselves
may influence the capacity (of UMM) to promote or
inhibit the different crystallization processes. Prominent
amongst these is monosodium urate which has been
shown to reduce the inhibitory potency of certain UMM
in inorganic solutions [12, 39, 54). Thus, conditions
operating in a batch crystalliz.er, for example, will pro-

have been employed [14, 32). These include batch [6,
10, 19, 20, 58), seed [3, 12, 19, 33, 36, 43, 52, 63],
continuous [9, 32, 42, 45), constant composition [34],
rotary evaporation [21, 24, 50, 51, 60), oxalate loading
[2, 5, 11, 18, 39, 55, 63], freezing [21, 60], paperwick
[56] and vapour diffusion [7] models. Hesse and coworkers [28] have correctly stated that crystallii.ation
systems are not identical, and that therefore different results are attributed to the specific characteristics of the
experiment. We wish to endorse this view and to elaborate upon it by suggesting that the activity of UMM is
539
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moters of calcium oxalate nucleation. The different conclusions drawn in the two studies are due to different
techniques used to monitor the crystallization processes.
These techniques are based on different sensing principles, and thus, data acquired by each will have different
significance and may elicit different interpretations.
Figure 2 shows that the final crystal volumes are in
the same sequence as crystal numbers. Thus, the volume of crystals formed in UF is greater than that formed
in other fractions. There are three mechanisms by
which this could occur. First, it could arise simply from
the presence of the largest number of particles in this
fraction (as shown in Fig. 1). This is consistent with
our suggestion that UMM are nucleation inhibitors.
Second, larger crystal volumes could occur in UF if bigger particles were present in this fraction. This implies
that UMM could be inhibitors of growth.
Third, when crystal aggregation occurs with accompanying entrapment of solution, "particle" volume will
increase. In such an event, the smaller particle volumes
observed in the presence of UMM (FILT and RET) suggest that UMM may be inhibitors of crystal aggregation.
Thus, Coulter Counter data, for this particular
specimen, yield several possibilities for the role of
UMM. The data suggest that UMM are probably nucleation inhibitors, but that they may also be growth and/or
aggregation inhibitors.
Flow cytometry data for total particle numbers in
the three fractions (Fig. 3) show the sequence FILT >
UF > RET. It is apparent that FILT and UF occupy
different positions in this sequence compared to that
observed by Coulter techniques. Nevertheless, in both
sequences FILT > RET and UF > RET, indicating that
particle numbers are lower in the fraction containing
concentrated levels ofUMM. We interpret these results
as suggesting that UMM in this sample are nucleation
inhibitors if they are present in high concentrations.
This supports our Coulter data but qualifies concentration as an important factor. The observation, by flow
cytometry, that FILT > UF indicates that, in this subject, UMM may be nucleation promoters when present
in normal concentrations. As has been mentioned earlier, the role played by UMM as promoters or inhibitors
is dependent on concentration. In a previous study involving urine from non-stone formers, we reported that
UMM are promoters of nucleation [47]. The present
study, involving stone forming urine has confirmed this
and shown that, at higher concentrations, inhibition
might occur.
Comparison of Figures 4, 5 and 6 shows that the
number of "very large" particles in all fractions is negligible. However, "large" particles are deficient in the
RET fractions, suggesting that UMM may be inhibitors
of growth and/or aggregation. "Small" and "medium"

duce a totally different milieu to that existing in a continuous crystallizer or rotary evaporator. We suggest
that the different conditions existing in the different crystallization systems induce a "ripple effect" in which numerous inter-related processes involving inhibition and
promotion of nucleation, growth and aggregation interact
with each other to finally produce a nett, system-dependent mechanism.
Detection and monitoring procedures
We believe that interpretation of the role played by
UMM in calcium oxalate crystallization depends upon
the very method used for the detection and monitoring
of the crystallization processes which are actually occurring in the samples under investigation. Detection procedures which have been employed are Coulter Counter
techniques [5, 11, 32, 45, 52, 55, 58], radioactive assay
[6, 12, 18, 19, 33, 36, 39, 43, 50, 51, 63], optical
methods [21, 24, 60], electron microscopy [11, 32, 55],
specific ion electrode [2, 34], particle analyzer (electrorone/celloscope counter type) [9, 42], nephelometry
[10, 22, 47, 48], colorimetry [20] and fluorimetry [56].
Because these techniques have different sensitivities and
detection limits, it is likely that they monitor different
stages and aspects of the crystallization processes which
are taking place. Therefore, interpretations based on
Coulter Counter measurements, for example, may differ
substantially from those based on turbidity determinations, even though the same urine specimen and the
same method of inducing crystallization are used. Discrepancies in interpretation are further compounded by
confusion with respect to the crystallization mechanism(s) (nucleation, growth or aggregation) that is (are)
actually being measured by the particular detection
process being used.
In the present study, calcium oxalate crystallization
was induced in different macromolecular fractions of the
same urine and was monitored by two independent techniques: Coulter Counter and flow cytometry. While the
former has been widely used for such studies, the latter
has only recently been implemented in the investigation
of urinary calcium oxalate crystallization [49]. Its application in the study of UMM has not been reported previously.
Figure 1 shows that after 90 minutes, the number of
particles formed in the different fractions are in the
sequence UF > FILT > RET. This demonstrates that
nucleation occurs to a lesser extent in the presence of
UMM than in its absence. A possible inference is that
UMM are inhibitors of calcium oxalate nucleation. This
contradicts findings of an earlier study of ours which
was conducted under similar conditions except that turbidimetry and Malvern particle size techniques were employed [47]. In that study, UMM were found to be pro-
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is constant in all the test solutions) or with those performed in whole urines. Although results obtained from
such solutions, i.e., aqueous or synthetic, provide useful
information about basic inhibition and promotion mechanisms, they are of limited value since data cannot be
extrapolated directly to real urine conditions.

particles follow a similar sequence which confirms this
effect. However, the inhibitory effect might only occur
in the concentrated RET fractions while an entirely different effect might occur when lower concentration levels of UMM are present.
The flow cytometer graphs for particle morphology
(Figs. 7, 8 and 9) show that there are significant numbers of two "types" present in all fractions. The existence of a second shape (whatever it might be) is interpreted as being indicative of aggregation. Numbers of
the predominant shape (type 1) follow the sequence RET
< UF < FILT while numbers of the aggregated shape
(type 2) follow the sequence RET < UF = FILT.
Thus, aggregation occurs to a lesser extent in RET fractions which have concentrated levels of UMM suggesting that the latter are inhibitors of aggregation. This
supports our interpretation of the size distribution data.
It may be further argued that since aggregation does not
occur to a great extent in RET, higher particle numbers
would be expected in this fraction . However, to the
contrary, lower numbers are recorded. This observation
provides further evidence in support of UMM being
inhibitors of nucleation.
Our SEM observations are unable to conclusively
demonstrate the role of UMM with respect to nucleation
and growth. However, the presence of aggregates in UF
samples and their absence in FILT and RET fractions
support our Coulter and cytometer data which suggest
that UMM are inhibitors of calcium oxalate aggregation.
We are unable to explain the presence of apatite in UF
samples.
It must be emphasized that it was not our intention
in this paper, nor was it an objective of the present
study, to make a definitive statement concerning the
effect of UMM on different crystallization mechanisms.
To do this , an in depth investigation involving many
urines would be required. Rather, we simply wish toillustrate that different techniques can lead to different,
and sometimes incomplete, conclusions. Indeed, inspection of Figures 1 and 3 shows that interpretation of the
kinetic plots at different stages of crystallization might
yield different conclusions. We also wish to use the
data, obtained from only one patient, to demonstrate that
flow cytometry provides very useful information and that
it might prove to be a valuable tool in this field, as has
been the case with the Coulter Counter.

Hypothetical standard crystallization model
Thus, the problem faced by investigators is that, in
order to make a meaningful and valid assessment of
their results, comparisons must be effected with other
studies in which precisely the same procedures and conditions were operative. Unfortunately, this is not easy
to achieve because of the wide diversity of experimental
systems that have been employed.
It is clear that a standard reference crystallization
model is required. Such a model should define: the
method by which the UMM are isolated, concentrated or
separated; the crystallization system itself, e.g . , continuous crystallizer or rotary evaporator; and a monitoring
procedure, e.g., Coulter or specific ion electrode, which
allows a distinction to be made between the various
crystallization mechanisms which might occur. It is also
of fundamental importance to define terminology [41].
Having described the features required of a standard
crystallization model, the challenge which must now be
addressed concerns identification of the various elements
of such a model which best satisfies or meets these requirements. Ideally, individual laboratories should undertake comparative studies in which different techniques
for separating UMM, different crystallizers and different
crystal monitoring procedures are investigated to establish which of these are most suitable and which combination of these best complement each other. Such an
approach would, no doubt, enable an appropriate system
to be defined. However, it is unlikely that any single
laboratory would be able to undertake studies of this nature because of obvious financial and logistical constraints. Therefore, any proposal for a standard reference model will have to be based on existing knowledge
and the documented experience of the many investigators
who have used a variety of crystallization systems in
their studies of UMM.
Consideration of the literature shows that the most
widely used method for the separation of UMM is ultrafiltration [2, 5, 11, 12, 21, 24, 31, 33 , 42, 47, 48, 50,
51, 55 , 60, 63] . Reservations have been expressed by
some authors that this procedure may modify the activity
of UMM [2, 34], but this does not appear to have been
demonstrated conclusively. Moreover, it has been
shown that urinary concentrations of sodium potassium
calcium, magnesium, phosphate, oxalate, ~rate, pyro~
phosphate and citrate are unaltered by this technique [ 11,
50], and that it does not affect the metastable limit of the

Crystallization mediwn
In the light of the above arguments, it should be obvious that the crystallization medium will be of crucial
importance in determining the nature of the crystallization which occurs. Thus, experiments carried out in
aqueous solutions or in synthetic urines cannot be compared with each other (unless the chemical composition
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urine [11, 55] . This technique has an advantage over dialysis since it yields two fractions for study, an ultrafiltrate and a concentrated retentate fraction, whereas the
latter yields only the retentate fraction . Therefore, we
propose that the standard method for separating and concentrating UMM be ultrafiltration.
Choice of the crystallizer itself, i.e., the method by
which crystallization is induced, is of paramount importance in establishing a standard reference model. Systems which attempt to simulate in vivo conditions and
crystallization processes must take precedence over those
which are far removed from physiological reality. The
mixed suspension, mixed product removal (MSMPR)
crystallizer (or continuous crystallizer) first proposed by
Finlayson [13) has been widely used in the study of calcium oxalate crystallization processes [8, 35, 46) including those involving UMM [9, 32, 42, 45). This system
reaches a steady state with a constant supersaturation,
and because it operates with continuous flow, individual
crystals remain in the suspension for a relatively short
time, similar to transit times through the kidney [30).
Unlike other methods, it permits the simultaneous but
independent measurement of nucleation and growth rates
[30). A detailed description of the theoretical and practical aspects of the MSMPR crystallizer is given by
Rodgers and Garside [46).
Although UMM investigations using this type of
crystallizer appear to have been limited to synthetic
urines [9, 32, 42, 45], a new method using "nearly"
whole urine has recently been developed [30). The effects of heparin and hyaluronic acid were tested successfully in the system. The MSMPR crystallizer is thus an
appropriate system for a standard reference crystallization model.
Although we are encouraged by our application of
flow cytometry to the study of UMM, we recognize that
such a facility is not readily available to all researchers.
Thus, of the different techniques used to detect and monitor crystallization, Coulter Counter procedures appear
to be the most versatile. Besides providing crystal size
and crystal volume distribution profiles, crystal growth
and aggregation can be measured, even when both are
occurring simultaneously [52). A further advantage of
using a Coulter Counter is its proven compatibility with
the MSMPR crystallizer described earlier [8, 40, 45,
46). Furthermore, by coupling these measurements to
SEM investigations [23, 55], a powerful approach for
differentiating between nucleation, growth and aggregation is achieved.
Since it is generally agreed that the role of any urinary component in promoting or inhibiting crystal formation is highly dependent on its chemical milieu, studies on the role of UMM should be conducted in whole,
real urines and not aqueous or synthetic solutions. Nor,

ideally, should filtered or sieved urine be used. Investigators will be aware that crystals in the urine contain
many macromolecules both on their surfaces as well as
within their own structure. Many of these are crystallization modulators like prothrombin, osteopontin and uromodulin. In addition, when cellular debris is removed,
much of the lipids and membranes are lost. Since it is
widely accepted that these substances are intimately involved in almost all physiological and pathological calcification processes, their removal depletes the urine of
crystallization promoters. Filtration may also remove
many urinary macromolecules like Tamm-Horsfall protein, osteopontin and albumin. Thus, urine which has
been sieved and filtered cannot be classified as "whole"
urine. However, most investigators will agree that
"whole" urine clogs up crystallizers and sensitive detectors, many of which use small apertures, e.g., Coulter
Counter. Use of "whole" urine is thus practically unfeasible; on the other hand, crystallization experiments
using filtered and sieved urine are far more likely to be
completed successfully. Thus, sieved and filtered urine
would have to be the medium of choice for the standard
system. Finally, since the excretion of many urinary
components varies diurnally, 24-hour urine specimens
should be used in these studies. The pH of the specimen
should not be altered as it is a natural determinant
property. Experiments should be performed at 37°C.
Of great interest would be a comparative study involving investigation of the same urine by the standardized protocol described in this paper and by other systems. Perhaps an inter-laboratory "quality control" type
of exercise could be implemented. Whatever the outcome, unless investigators standardize their whole
approach to the investigation of urinary macromolecular
activity, discrepancies and lack of consensus on their
role in urolithiasis are inevitable.
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J.P. Kavanagh: It is not clear to me if a single experiment was performed for each urinary fraction, with sampling at intervals for analysis by Coulter Counter and
flow cytometry, or if separate experiments were performed . Factors other than the measuring technique
might also influence the outcome of the crystallization
experiments reported. Were there any differences in
such details as sample age, vessel geometry or stirring?
Authors: A single experiment with sampling at various
times was performed. Since only one sample was used,
age was not a variable. Vessel geometry and stirring
were constant.

Discussion with Reviewers

J.P. Kavanagh: I share the authors' concern about the

Reviewer I: What was the reproducibility of the
results? For example, are the differences between UF
and FILT significant?
Authors: The reproducibility of the system was tested
by measuring the calcium oxalate crystallization kinetics
6 times in FILT fractions from each of three different
urines. The coefficient of variation was 13 %. Kinetic
data obtained in the experiments involving the urine
reported in this paper were tested for significant differences by assuming that particle numbers and volumes
have Poisson distributions [64]. All data were significantly different after 90 minutes.

system dependence of results and the associated difficulties in interpretation that this can lead to, but would a
reference crystallization method resolve this difficulty?
It is doubtful if any one method would always be appropriate for the questions being asked by different investigators. On the other hand, there could be some merit in
being able to compare baseline descriptions of crystallization modifying properties of urines or urinary fractions
being tested.
Authors: Investigators are using many different systems
to answer a set of questions of common interest. Perhaps an inter-laboratory "quality control" series of
experiments (as discussed between the reviewer and
author) might provide some (consistent) answers.

Reviewer I: What was the osmolality of the urine?
Authors: Osmolality was not measured.
Reviewer I: The 24-hour collection may not resemble
urine as actually passed. What are your comments?
Authors: While you are correct in expressing this concern, collection of 24-hour urine specimens for study is
a widely practiced protocol. Whatever collection is effected (early morning, random, 12-hour, etc.), limitations will always be present.

S. Ebisuno: In Figures 7 to 9, two particle crystals
show different patterns. However, it is impossible to
understand the morphological difference because of lack
of microscopy.
Authors: The cytometer data only indicate a qualitative
difference in particle morphology. In this study, two
such shapes were detected; these have been interpreted
as being associated with nucleation and aggregation.
Although direct correlation with SEM studies was not
achieved, examples of both mechanisms were observed
using the latter technique.

J.P. Kavanagh: What was the ratio of the volumes of
the RET and UF fractions at the end of the ultrafiltration? Any standard protocol for preparation of UMM
should include this detail and also define sample collection and pre-treatment.
Authors: The UF volume was 120 cm3 while that of
the RET was 60 cm3 • Since the original volume of
FILT in the ultrafiltration cell was 180 cm3, the RET
fraction was concentrated by a factor of three. This
concentration factor is recommended for the standard
protocol as a larger one would be too far removed from
physiological conditions while a smaller one might not
induce detectable effects. Samples should be collected

S. Ebisuno: How do you confirm the apatite deposits
with embedded calcium oxalate dihydrate crystals in
Figure 13?
Authors: These deposits were confirmed by energy dispersive X-ray analysis which revealed the presence of
Ca and P in the former and Ca in the latter.
S. Ebisuno: The inhibitory activity of UMM on calcium oxalate crystal growth and/or aggregation is depend545
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ent on ionic strength (65]. Were there any differences
in the ionic strengths of the three urinary fractions?
Authors: This is a good point. Unfortunately, ionic
strengths in the various urinary fractions were not
determined.

R.L. Ryall: I am most concerned about Figure 12.
This micrograph clearly shows the presence of two red
blood cells, and this suggests that the patient had
haematuria. His urine therefore would have contained
any number of additional macromolecules not found in
urine under normal conditions. These would have affected the inhibitory potency of the FILT and RET fractions and their activity relative to the UF specimen. The
presence of these red blood cells in urine that had been
ultrafiltered indicates either that (a) the ultrafiltration
was incomplete (the membrane may have been defective)
or (b) the urine sample was later contaminated with
blood, the patient's or someone else's. In either case,
the validity of the data must be questioned.
Authors: The two deposits referred to are not red blood
cells. All our urine specimens used in crystallization
and other studies are routinely tested for the presence of
haematuria [49] using a Boehringer Mannheim Combur
9 test strip (Boehringer, Mannheim, Germany). Urines
which test positive are discarded [49]. The urine which
was used in the present study was thus free of blood
prior to ultrafiltration. We have seen these deposits, the
morphology of which closely resembles that of red blood
cells, in several of our crystallization experiments using
urine from normal and stone-forming subjects. Energy
dispersive (spot) X-ray analysis has revealed the
presences of Na, K, S and Cl in these deposits.
Therefore, it is likely that they are salts which have
crystallized during our experiments.

R.L. Ryall: Advances in protein chemistry and immunological techniques have enabled us to study the effects
of individual, identified urinary macromolecules on calcium oxalate crystallization. Do the authors feel that
useful information will be derived from studies based
simply on global removal of all urinary macromolecules?
Authors: Removal of all urinary macromolecules will
identify the size ranges that are of importance. By careful selection of membranes with different cut-offs, the
effective size range can be accurately defined. Perhaps
thereafter, immunological techniques should be used to
identify the urinary macromolecules within such a range.
R.L. Ryall: A call was made 15 years ago (reference
41) for a standard system of nomenclature in urolithiasis
research. Though more simple than a standard experimental model, universal use of a reference nomenclature
has never been achieved. How feasible would be the
implementation of a standard reference model for studying the inhibitory or promotory effects of macromolecules or other agents?
Authors: The feasibility is directly dependent on the
extent to which investigators are honest enough to recognize that standardization of nomenclature, and a reference model would not only decrease the confusion that
exists in this area of stone research but would also clarify the inhibitory and promotory role of urinary macromolecules and other agents.
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